These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10612580)

  • 21. [Comparison of bronchodilator effects and site of action of fenoterol and ipratropium in chronic obstructive bronchitis].
    Kheir A; Ying Y; Hannhart B; Duvivier C; Peslin R; Polu JM
    Rev Mal Respir; 1993; 10(1):9-15. PubMed ID: 8451502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group.
    van Noord JA; Bantje TA; Eland ME; Korducki L; Cornelissen PJ
    Thorax; 2000 Apr; 55(4):289-94. PubMed ID: 10722768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease.
    van Noord JA; Smeets JJ; Custers FL; Korducki L; Cornelissen PJ
    Eur Respir J; 2002 Apr; 19(4):639-44. PubMed ID: 11998992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nebulization
    Lu R; Li Y; Hu C; Pan P; Zhao Q; He R
    Ther Adv Respir Dis; 2023; 17():17534666231214134. PubMed ID: 38073272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-response relationship: fenoterol, ipratropium bromide and their combination.
    Ciappi G; Magnini P; Valente S; Toscano L; Corbo GM; Culla G; Patalano F
    Respiration; 1986; 50 Suppl 2():140-3. PubMed ID: 2951792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The short-term bronchodilator effects of fenoterol and ipratropium in asthma.
    Elwood RK; Abboud RT
    J Allergy Clin Immunol; 1982 May; 69(5):467-73. PubMed ID: 6210726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy.
    Congleton J; Muers MF
    Respir Med; 1995 Apr; 89(4):291-6. PubMed ID: 7597269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique.
    Brand P; Hederer B; Austen G; Dewberry H; Meyer T
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):763-70. PubMed ID: 19281091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bronchodilator response of advanced lung function parameters depending on COPD severity.
    Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction.
    Barros MJ; Rees PJ
    Respir Med; 1990 Sep; 84(5):371-5. PubMed ID: 2147295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of inhaled oxitropium and fenoterol, alone and in combination, in chronic airflow obstruction.
    Frith PA; Jenner B; Atkinson J
    Respiration; 1986; 50 Suppl 2():294-7. PubMed ID: 3563116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the safety of drug delivery via HFA- and CFC-metered dose inhalers in CAO.
    Huchon G; Hofbauer P; Cannizzaro G; Iacono P; Wald F
    Eur Respir J; 2000 Apr; 15(4):663-9. PubMed ID: 10780756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease.
    Friedman M
    Am J Med; 1996 Jan; 100(1A):30S-39S. PubMed ID: 8610715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solution assessing dose-response and duration of action.
    McIntosh D
    Respiration; 1986; 50 Suppl 2():310-2. PubMed ID: 2951827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of asthma bronchiale with a combination of ipratropium bromide and fenoterol.
    Sahlström K; Alanko K; Härkönen R
    Respiration; 1986; 50 Suppl 2():302-9. PubMed ID: 2951826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of fenoterol, ipratropium bromide and their combination--Berodual--on pulmonary ventilation in patients with asthma].
    Chyrek-Borowska S; Rutkowski R; Michalska I; Hofman J
    Pol Tyg Lek; 1989 Jul; 44(27):642-5. PubMed ID: 2534666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease.
    Colice GL
    Am J Med; 1996 Jan; 100(1A):11S-18S. PubMed ID: 8610712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fenoterol delivery by Respimat soft mist inhaler versus CFC metered dose inhaler: cumulative dose-response study in asthma patients.
    Vincken W; Dewberry H; Moonen D
    J Asthma; 2003 Sep; 40(6):721-30. PubMed ID: 14580004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of bronchodilatation produced by an anticholinergic (ipratropium bromide), a beta-2 adrenergic (fenoterol) and their combination in patients with chronic obstructive airway disease. An open trial.
    Guleria R; Behera D; Jindal SK
    J Assoc Physicians India; 1991 Sep; 39(9):680-2. PubMed ID: 1839993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.